Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Infliximab Produkte

(Infliximab)

Kategorien

antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.

Empfohlene Infliximab Antikörper

Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human
Applikation ELISA
Validierungen
Kat. Nr. ABIN7514439
Menge 40 μg
Datenblatt Datenblatt

Empfohlene Infliximab ELISA Kits

Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität Human, Monkey, Mouse, Rat
Analytical Method Quantitative Sandwich ELISA
Validierungen
  • (1)
Kat. Nr. ABIN2862648
Menge 96 tests
Datenblatt Datenblatt

Neueste Publikationen zu unseren Infliximab Produkten

Beswick, Rosella, Rosella, Headon, Sparrow, Gibson, van Langenberg: "Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study." in: Journal of Crohn's & colitis, Vol. 12, Issue 3, pp. 289-297, (2018) (PubMed).

Kang, Choi, Choi, Kim, Kim, Lee, Choe et al.: "Subtherapeutic Infliximab Trough Levels and Complete Mucosal Healing Are Associated With Sustained Clinical Remission After Infliximab Cessation in Paediatric-onset Crohn's Disease Patients Treated ..." in: Journal of Crohn's & colitis, Vol. 12, Issue 6, pp. 644-652, (2018) (PubMed).

Fleisher, Ait-Oudhia: "A retrospective examination of the US Food and Drug Administration's clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring." in: OncoTargets and therapy, Vol. 11, pp. 113-121, (2018) (PubMed).

Ohem, Hradsky, Zarubova, Copova, Bukovska, Prusa, Malickova, Bronsky: "Evaluation of Infliximab Therapy in Children with Crohn's Disease Using Trough Levels Predictors." in: Digestive diseases (Basel, Switzerland), Vol. 36, Issue 1, pp. 40-48, (2018) (PubMed).

Piñero, Juanola, Gutiérrez, Zapater, Giménez, Steinert, Sempere, González-Navajas, Niess, Francés: "IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA." in: Journal of molecular medicine (Berlin, Germany), Vol. 95, Issue 11, pp. 1227-1236, (2018) (PubMed).

Aomori, Tsuchiya, Suzuki, Jibiki, Otsuka, Ishioka, Kaneko, Takeuchi, Nakamura: "Suppression of infliximab antibody levels by azathioprine in patients with rheumatoid arthritis." in: Die Pharmazie, Vol. 72, Issue 2, pp. 95-97, (2018) (PubMed).

Choi, Kang, Lee, Choe: "Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease." in: Gut and liver, Vol. 11, Issue 1, pp. 55-61, (2017) (PubMed).

Bálint, Rutka, Végh, Kürti, Gecse, Banai, Bene, Gasztonyi, Kristóf, Lakatos, Miheller, Palatka, Patai, Salamon, Szamosi, Szepes, Tóth, Vincze, Bor, Milassin, Fábián, Nagy, Kolar, Bortlik, Duricova et al.: "Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. ..." in: Expert opinion on drug safety, Vol. 16, Issue 8, pp. 885-890, (2017) (PubMed).

Kolar, Duricova, Bortlik, Hruba, Machkova, Mitrova, Malickova, Lukas, Lukas: "Infliximab Biosimilar (Remsima™) in Therapy of Inflammatory Bowel Diseases Patients: Experience from One Tertiary Inflammatory Bowel Diseases Centre." in: Digestive diseases (Basel, Switzerland), Vol. 35, Issue 1-2, pp. 91-100, (2017) (PubMed).

Gibellini, De Biasi, Bianchini, Bartolomeo, Fabiano, Manfredini, Ferrari, Albertini, Trenti, Nasi, Pinti, Iannone, Salvarani, Cossarizza, Pellacani: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." in: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).

Sie sind hier:
Kundenservice